This inventor holds 1 USPTO granted patent. Top assignee: American Cyanamid Company. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Marvin E. Reich: Innovator in Vasopressin Antagonists
Introduction
Marvin E. Reich is a notable inventor based in Rockland, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that exhibit vasopressin antagonist activity. His work has implications for treating diseases characterized by excess renal reabsorption of water.
Latest Patents
Reich holds a patent for "Tricyclic benzazepine vasopressin antagonists." This patent describes a tricyclic compound of the general Formula I, which exhibits antagonist activity at V1 and/or V2 receptors. The compounds outlined in his patent demonstrate in vivo vasopressin antagonist activity and provide methods for treating related diseases.
Career Highlights
Marvin E. Reich has worked with the American Cyanamid Company, where he has been involved in innovative research and development. His expertise in pharmacology and chemistry has led to advancements in therapeutic compounds.
Collaborations
Reich has collaborated with notable colleagues, including Jay Donald Albright and Efren Guillermo Delos Santos. These partnerships have contributed to the success of his research and the development of new pharmaceutical solutions.
Conclusion
Marvin E. Reich's contributions to the field of pharmacology, particularly through his patent on vasopressin antagonists, highlight his role as an innovator. His work continues to influence the treatment of conditions related to water reabsorption in the body.